| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/26/2010 | EP2188015A2 Use of salusin beta alone or in combination with octreotide as a therapeutic agent |
| 05/26/2010 | EP2187956A2 Use of a laminin peptide as a therapeutic agent |
| 05/26/2010 | EP2187952A1 Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agents |
| 05/26/2010 | EP2187950A1 Use of insulin c-peptide, alone or in combination with glp-1, as a therapeutic agent |
| 05/26/2010 | EP2187949A2 Use of glp-1 as a therapeutic agent |
| 05/26/2010 | EP2187948A2 Use of a peptide as a therapeutic agent |
| 05/26/2010 | EP2187947A2 Use of calcitonin as anti-angiogenic agent |
| 05/26/2010 | EP2187946A1 Use of a peptide as a therapeutic agent |
| 05/26/2010 | EP2187945A2 Use of a peptide as a therapeutic agent |
| 05/26/2010 | EP2187934A1 Use of fertirelin and delta-endorphin as therapeutic agents |
| 05/26/2010 | EP2187930A2 Trap-14 as a therapeutic agent |
| 05/26/2010 | EP2187924A2 Use of a peptide as a therapeutic agent |
| 05/26/2010 | EP2187917A2 Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agent |
| 05/26/2010 | EP2187915A2 Use of the peptide phpfhlfvy (renin inhibitor) as a therapeutic agent |
| 05/26/2010 | EP2187909A1 Use of bpp-b as a therapeutic agent |
| 05/26/2010 | EP2187901A2 Therapeutic use of neuropeptide ei and a acth 7-38 and compositions thereof |
| 05/26/2010 | EP2187895A1 Composition containing microrna-21 inhibitor for enhancing radiation sensitivity |
| 05/26/2010 | EP2187886A1 Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt |
| 05/26/2010 | EP2187878A2 Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
| 05/26/2010 | EP2187803A1 Multimodality agents for tumor imaging and therapy |
| 05/26/2010 | EP2187741A1 Novel forms of cddo methyl ester |
| 05/26/2010 | EP2079724B1 Substituted pyridone compounds and methods of use |
| 05/26/2010 | EP1951730B1 Heteroalkyl linked pyrimidine derivatives |
| 05/26/2010 | EP1896470B1 Pyrrolopyridine derivatives as protein kinase inhibitors |
| 05/26/2010 | EP1844048B1 Pyrazolopyrimidines as cell cycle kinase inhibitors |
| 05/26/2010 | EP1718737B1 Cancerous disease modifying antibodies |
| 05/26/2010 | EP1578426B1 Combination of a nitrogen mustard analogue and imatinib for the treatment of chronic lymphocytic leukemia |
| 05/26/2010 | EP1448602B1 Modified anti-tnf alpha antibody |
| 05/26/2010 | EP1424998B1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 05/26/2010 | EP1315709B1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 05/26/2010 | EP1272665B1 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 05/26/2010 | CN1984656B Cancer treatment method |
| 05/26/2010 | CN1974598B Isolated proteins from a traditional Chinese medicine yuzhu and use thereof |
| 05/26/2010 | CN1969814B Nasal administered preparation of melatonin |
| 05/26/2010 | CN1961896B Effective part of Chinese medicinal pseudolarix in inhibiting angiogenesis |
| 05/26/2010 | CN1956725B Antineoplastic agent |
| 05/26/2010 | CN1935277B Preparation for the prophylaxis of restenosis |
| 05/26/2010 | CN1915991B Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 05/26/2010 | CN1912111B Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen |
| 05/26/2010 | CN1910153B Derivatives of pyridine and quinoline |
| 05/26/2010 | CN1895546B Lycium chinensis polyose medicinal composition with therapeutic and health-care functions |
| 05/26/2010 | CN1879615B Anti-tumor synergistic pharmaceutical composition |
| 05/26/2010 | CN1875022B Tocopherol-modified therapeutic drug compounds |
| 05/26/2010 | CN1867331B Thalidomide analogs as TNF-alpha modulators |
| 05/26/2010 | CN1845938B Polypeptides |
| 05/26/2010 | CN1842337B Stable 5,10-methylene-tetrahydrofolate pharmaceutical compounds |
| 05/26/2010 | CN1816626B Antisense oligonucleotide having anticancerous activity |
| 05/26/2010 | CN1805748B 2-aminopyrimidine derivatives as RAF kinase inhibitors |
| 05/26/2010 | CN1791433B DNA vaccines against tumor growth and methods of use thereof |
| 05/26/2010 | CN1756763B Dimerized peptide |
| 05/26/2010 | CN1744902B Pharmaceutical combination for the treatment of cancer |
| 05/26/2010 | CN1726217B Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 05/26/2010 | CN1709497B Miao-medicine composition and its use |
| 05/26/2010 | CN1699401B Novel anti-cancer active compound and its extraction process |
| 05/26/2010 | CN1681811B Azolidinone-vinyl fused-benzene derivatives |
| 05/26/2010 | CN1671412B Immunostimulatory compositions and methods of stimulating an immune response |
| 05/26/2010 | CN1668637B Molecular antigen arrays using a virus like particle derived from the AP205 coat protein |
| 05/26/2010 | CN1665934B GNTIII(UDP-N-acetylglucosamine:beta-D mannoside beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants |
| 05/26/2010 | CN1665933B Immunoconjugates for the treatment of tumours |
| 05/26/2010 | CN1656073B Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 05/26/2010 | CN1638807B Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy |
| 05/26/2010 | CN1604795B Combination motif immune stimulatory oligonucleotides with improved activity |
| 05/26/2010 | CN1596313B Humanized collagen antibodies and related methods |
| 05/26/2010 | CN1578678B Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 05/26/2010 | CN1468308B Anti-TNF antibodies, compositions, methods and uses |
| 05/26/2010 | CN1425066B Novel stra6 polypeptides |
| 05/26/2010 | CN101715453A heterocyclic compounds and their uses |
| 05/26/2010 | CN101715451A Novel pyridopyrazine derivatives, process of manufacturing and uses thereof |
| 05/26/2010 | CN101715448A The therapeutic uses of imidazol-5-carboxylic acid derivatives |
| 05/26/2010 | CN101715345A Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha |
| 05/26/2010 | CN101715344A Use of HDAC inhibitors for the treatment of bone destruction |
| 05/26/2010 | CN101715341A Method for the preparation of biocompatible polymeric nanoparticles for drug delivery and nanoparticles prepared thereby |
| 05/26/2010 | CN101712964A Fusion protein for inhibiting formation of osteoclast and preparation method as well as pharmaceutical composition thereof |
| 05/26/2010 | CN101712960A Mac-2BP tumor antigen gene, protein, antibody and application thereof |
| 05/26/2010 | CN101712959A Novel human cell growth inhibiting gene THAP11 and application thereof |
| 05/26/2010 | CN101712958A Novel human tumor inhibiting gene KIAA0157 and application thereof |
| 05/26/2010 | CN101712798A Compound consisting of metal nano-particles and cell membrane biomimetic-modification arborized polyamide-amine and preparation method |
| 05/26/2010 | CN101712721A T cell receptor fusions and conjugates and methods of use thereof |
| 05/26/2010 | CN101712720A Human antibodies that bind human TNF alpha |
| 05/26/2010 | CN101712714A Semisynthetic trierpenoidsaponin with antitumor activity and medicinal composition thereof |
| 05/26/2010 | CN101712711A Sterol from sponge, preparation method and application thereof |
| 05/26/2010 | CN101712710A LMP1targeted oligonucleotide and application thereof serving as radiotherapeutic sensitizer |
| 05/26/2010 | CN101712708A Method for preparing decitabine |
| 05/26/2010 | CN101712700A Alkyl galactoside receptor, preparation method and application thereof |
| 05/26/2010 | CN101712669A Method for separating and purifying luteolin |
| 05/26/2010 | CN101712660A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 05/26/2010 | CN101712655A Acetamide derivative and application thereof in pharmacy |
| 05/26/2010 | CN101712642A 5 site-sodium thiosulfate substituted elsinochrome derivative and preparation method and application thereof |
| 05/26/2010 | CN101711872A Nano gold spherical shell material, preparation method and application in preparing medicaments for treating tumors |
| 05/26/2010 | CN101711871A Silver nano-chain meshed material, preparation method thereof and application in preparing medicine for curing tumor |
| 05/26/2010 | CN101711868A Gene detection assay for improving the likelihood of an effective response to a ErbB antibody cancer therapy |
| 05/26/2010 | CN101711866A Method for identifying tumors that are responsive to treatment with anti-ErbB2 antibodies |
| 05/26/2010 | CN101711858A Medicine for treating cancer |
| 05/26/2010 | CN101711855A Traditional Chinese medicine preparation for treating gastric cancer and preparation method |
| 05/26/2010 | CN101711849A Traditional Chinese medicine composition for treating symptoms of qi stasis, blood stasis, myoma and cyst and preparation method |
| 05/26/2010 | CN101711845A Traditional Chinese medicine for treating lung cancer |
| 05/26/2010 | CN101711840A Medicine-food dual-purpose composition suitable for cancerous patients and preparation method thereof |
| 05/26/2010 | CN101711829A Dripping pill for treating mammary cancer |
| 05/26/2010 | CN101711812A Method for preparing oleanolic acid capsule of Chaenomeles speciosa Nakai leaves |
| 05/26/2010 | CN101711790A Wild Juglans mandshurica bark water extract used for curing liver cancer |